Selective Endothelin A-Receptor Blockade Attenuates Coronary Microvascular Dysfunction After Coronary Stenting in Patients With Type 2 Diabetes
Vascular Health and Risk Management
doi 10.2147/vhrm.s7867
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2009
Authors
Publisher
Informa UK Limited